Activity: Consultancy types › Consultancy
Amphista Therapeutics is the leading Europe-based targeted protein degradation (TPD) company. Founded by Advent Life Sciences, Amphista is built on the groundbreaking science from the laboratory of Professor Alessio Ciulli, University of Dundee, a world leader in the field of targeted protein degradation.